In Treatment of Menstrual pain Uzispas 10mg/250mg Tablet is a combination medicine that helps reduce pain and cramps during periods. It stops sudden muscle contractions (spasms) and blocks the release of certain chemical messengers that cause pain and inflammation, thereby relieving cramps, pain, bloating, and discomfort. This medicine does not affect the amount or the duration of menstrual bleeding. Take this medicine as per the dose and duration prescribed by your doctor. In Treatment of Abdominal cramp Uzispas 10mg/250mg Tablet gives relief from abdominal pain and cramps. It works best if they are used when the first signs of pain occur. It relaxes the muscles in the stomach and intestine and stops sudden muscle contractions or spasms. Uzispas 10mg/250mg Tablet also blocks the activity of certain chemicals that causes pain. Take it as prescribed by the doctor for maximum benefits.
Caution is advised when consuming alcohol with Uzispas 10mg/250mg Tablet. Please consult your doctor.
Information regarding the use of Uzispas 10mg/250mg Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Uzispas 10mg/250mg Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Uzispas 10mg/250mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Uzispas 10mg/250mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Uzispas 10mg/250mg Tablet may be needed. Please consult your doctor. Use of Uzispas 10mg/250mg Tablet is not recommended in patients with severe kidney disease.
Uzispas 10mg/250mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Uzispas 10mg/250mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Uzispas 10mg/250mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Samson Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Synokem Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: NV Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vibcare Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: SB Lifesciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: SandMartin Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Frank Medilink || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nukind Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Insight Labz || ₹14.5/tablet (25% cheaper)